Inosine

Synthetic derivative of purine with immunomodulatory and virustatic properties. Intermediate product of purine metabolism (purine nucleoside). Effectiveness is controversial.

For immune stimulation in viral diseases, especially subacute sclerosing panencephalitis, herpes simplex, zoster, measles, cytomegaly and Epstein-Barr virus infection.

Strict indication position! There is no sufficient experience with pregnant women or mothers in the lactation period.

• Herpes simplex infections: adults 6-8 tbl/day depending on the severity of the disease (one tbl every 2-3 hours), children 1/2-6 tbl spread over several doses throughout the day (50-100 mg active substance/kg bw/day).
• Viral infections in immunocompromised patients: adults: 50 mg divided into 3-5 doses, children 100 mg active substance mixture/kg bw/day divided into 2-4 doses.

Temporary increase of the uric acid level in serum and urine (caused by the metabolism of inosine) Allergic reactions to inosine or other ingredients of the drug preparation (especially urticaria, erythema), in very rare cases anaphylactic shock.

Purine metabolism disorders (gout, hyperuricemia), renal insufficiency, urinary and kidney stone disorders, tendency to extrasystoles, cerebral seizure disorders, gastric disorders, autoimmune disorders and celiac disease.

Isoprinosines